Comparing Medicines to Reduce Pain, Swelling, and Discomfort After Wisdom Tooth Surgery

Comparative evaluation of dexamethasone, vitamin-c and platelet growth factors in postoperative sequelae of impacted third molar: Randomised Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100924

Enrollment

120

Registered

2026-01-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K011- Impacted teeth

Interventions

Intervention1: Gelfoam impregnated with concentrated growth factors, vitamin C, and dexamethasone: total 14 Postoperative days. Patient is followed up on day 3, 1 week and 2 weeks Control Interventio

Eligibility

Inclusion criteria

Inclusion criteria: Patients categorized under ASA-I and ASA-II health status Mesioangular, Position B, Level 2 mandibular third molar impaction

Exclusion criteria

Exclusion criteria: Pregnant & Lactating mother Patient having active infection in or around surgical site Patients on long-term steroid therapy Patients not willing to participate in the study

Design outcomes

Primary

Measure	Time frame
1.Pain assessment (VAS Scale) 2.Swelling evaluation (Facial measurements) 3.Mouth opening (Interincisal width) Timepoint: Day 3, 1 week, and 2 weeks postoperatively	—

Secondary

Measure	Time frame
Analgesic consumptionTimepoint: Day 3, 1 week, and 2 weeks postoperatively	—

Countries

India

Contacts

Public ContactDR AMBHUJA AGRAWAL

SARASWATI DENTAL COLLEGE

dr.irfanhaji@yahoo.com9596477410

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026